Linking youth to PrEP (HIV prevention) services
Part of Infections clinical trials.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 13 and 24 years old
- You have had anal or vaginal sex in the past year
- You are not currently living with HIV
- You weigh at least 77 pounds (35 kilograms)
- You are willing to get PrEP from a participating clinic or community location
- You have an iPhone or Android smartphone and can read and speak English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program called PrEP Choice to help young people learn about and start PrEP, a daily pill that prevents HIV. It aims to see if offering choices in PrEP care makes it easier to use.
This trial trains primary care providers at certain clinics to better offer PrEP, a daily pill that prevents HIV, to adolescents and young adults. If you are a provider at one of the listed clinics, you may be able to help improve how this prevention is delivered.
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
This study offers a way for adolescent girls and young women in Tanzania to get PrEP (a daily pill that helps prevent HIV) from local pharmacies instead of only from clinics. It aims to make starting and staying on PrEP easier and more convenient.
This trial looks at how well a daily HIV-prevention pill (F/TAF) works in people who use drugs. The goal is to understand real-world effectiveness and help support people in staying HIV-negative.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.